Capital Investment Advisors’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-2,175
Closed -$205K 526
2019
Q1
$205K Buy
+2,175
New +$190K 0.01% 452
2018
Q4
Sell
-2,839
Closed -$254K 512
2018
Q3
$254K Buy
2,839
+312
+12% +$27.6K 0.02% 426
2018
Q2
$201K Sell
2,527
-275
-10% -$22.8K 0.01% 463
2018
Q1
$250K Sell
2,802
-32
-1% -$3.07K 0.02% 416
2017
Q4
$296K Buy
2,834
+215
+8% +$24.3K 0.02% 388
2017
Q3
$382K Sell
2,619
-172
-6% -$23.4K 0.03% 330
2017
Q2
$362K Buy
2,791
+397
+17% +$48.6K 0.03% 334
2017
Q1
$298K Sell
2,394
-105
-4% -$12.6K 0.02% 366
2016
Q4
$289K Buy
2,499
+63
+3% +$7.02K 0.02% 356
2016
Q3
$255K Sell
2,436
-177
-7% -$19.2K 0.02% 367
2016
Q2
$258K Sell
2,613
-1,490
-36% -$154K 0.02% 358
2016
Q1
$411K Buy
4,103
+94
+2% +$9.68K 0.04% 277
2015
Q4
$480K Buy
+4,009
New +$464K 0.05% 255

Other funds holding CELG

Capital Investment Advisors's CELG Position: Q2 2019 in Review

Capital Investment Advisors sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,175 shares — an estimated $205K sold.

Capital Investment Advisors first reported a position in CELG in Q4 2015 and held it in 13 quarters. The position peaked at $480K in Q4 2015. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Capital Investment Advisors reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Capital Investment Advisors sold 2,175 Celgene Corp shares in Q2 2019, an estimated $205K.
  • Capital Investment Advisors first reported a position in Celgene Corp in Q4 2015 and held it in 13 quarters.
  • Capital Investment Advisors's Celgene Corp position peaked at $480K in Q4 2015.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Capital Investment Advisors's 13F filing for Q2 2019, filed 17 Jul 2019.